SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
07-Jun-24 4:03 PM View: | Sinclair Andrew Director | Adicet Bio, Inc. (ACET) | 05-Jun-24 | Grant | 5,900 | -- | -- | 100% 5.9K to 11.8K | |
07-Jun-24 4:07 PM View: | Chodakewitz Jeffrey Director | Adicet Bio, Inc. (ACET) | 05-Jun-24 | Grant | 5,900 | -- | -- | 100% 5.9K to 11.8K | |
07-Jun-24 4:05 PM View: | Dubin Steve Director | Adicet Bio, Inc. (ACET) | 05-Jun-24 | Grant | 5,900 | -- | -- | 54% 10.9K to 16.8K | |
07-Jun-24 4:05 PM View: | Kauffman Michael Director | Adicet Bio, Inc. (ACET) | 05-Jun-24 | Grant | 5,900 | -- | -- | 100% 5.9K to 11.8K | |
07-Jun-24 4:08 PM View: | Gordon Carl L Director 10% Owner | Adicet Bio, Inc. (ACET) | 05-Jun-24 | Grant | 5,900 | -- | -- | < 1% 11.45M to 11.46M | |
07-Jun-24 4:05 PM View: | Kauffman Michael Director | Adicet Bio, Inc. (ACET) | 05-Jun-24 | Sale | 5,900 | $1.43 | $8,437.00 | (50%) 11.8K to 5.9K | |
07-Jun-24 4:04 PM View: | Peng Katie Director | Adicet Bio, Inc. (ACET) | 05-Jun-24 | Grant | 5,900 | -- | -- | 100% 0 to 5.9K | |
07-Jun-24 4:06 PM View: | Jakobovits Aya Director | Adicet Bio, Inc. (ACET) | 05-Jun-24 | Grant | 5,900 | -- | -- | < 1% 856.66K to 862.56K | |
26-Jan-24 7:13 PM View: | Gordon Carl L Director 10% Owner | Adicet Bio, Inc. (ACET) | 25-Jan-24 | Private Purchase | 3,125,000 | $2.40 | $7,500,000.00 | 38% 8.32M to 11.45M | |
26-Jan-24 7:14 PM View: | Orbimed Advisors LLC Director 10% Owner | Adicet Bio, Inc. (ACET) | 25-Jan-24 | Private Purchase Duplicate | 3,125,000 | $2.40 | $7,500,000.00 | 38% 8.32M to 11.45M | |
26-Jan-24 7:08 PM View: | Harvey Brian Nicholas Chief Financial Officer | Adicet Bio, Inc. (ACET) | 24-Jan-24 | Payment of Exercise | 4,320 | $2.40 | $10,368.00 | (4%) 104.12K to 99.8K | |
26-Jan-24 7:06 PM View: | Schor Chen President & CEO Director | Adicet Bio, Inc. (ACET) | 24-Jan-24 | Grant | 70,300 | -- | -- | 28% 250.65K to 320.95K | |
26-Jan-24 7:09 PM View: | Healey Don Chief Technology Officer | Adicet Bio, Inc. (ACET) | 24-Jan-24 | Payment of Exercise | 4,870 | $2.40 | $11,688.00 | (6%) 77.2K to 72.33K | |
26-Jan-24 7:11 PM View: | Galimi Francesco SVP & Chief Medical Officer | Adicet Bio, Inc. (ACET) | 24-Jan-24 | Payment of Exercise | 4,957 | $2.40 | $11,896.80 | (5%) 106.76K to 101.8K | |
26-Jan-24 7:06 PM View: | Schor Chen President & CEO Director | Adicet Bio, Inc. (ACET) | 24-Jan-24 | Payment of Exercise | 15,290 | $2.40 | $36,696.00 | (5%) 320.95K to 305.66K | |
26-Jan-24 7:10 PM View: | Aftab Blake Chief Scientific Officer | Adicet Bio, Inc. (ACET) | 24-Jan-24 | Grant | 19,700 | -- | -- | 42% 46.38K to 66.08K | |
26-Jan-24 7:08 PM View: | Harvey Brian Nicholas Chief Financial Officer | Adicet Bio, Inc. (ACET) | 24-Jan-24 | Grant | 26,300 | -- | -- | 34% 77.82K to 104.12K | |
26-Jan-24 7:10 PM View: | Aftab Blake Chief Scientific Officer | Adicet Bio, Inc. (ACET) | 24-Jan-24 | Payment of Exercise | 3,565 | $2.40 | $8,556.00 | (5%) 66.08K to 62.51K | |
26-Jan-24 7:09 PM View: | Healey Don Chief Technology Officer | Adicet Bio, Inc. (ACET) | 24-Jan-24 | Grant | 19,700 | -- | -- | 34% 57.5K to 77.2K | |
26-Jan-24 7:11 PM View: | Galimi Francesco SVP & Chief Medical Officer | Adicet Bio, Inc. (ACET) | 24-Jan-24 | Grant | 26,300 | -- | -- | 33% 80.46K to 106.76K | |
16-Oct-23 4:11 PM View: | Aftab Blake Chief Scientific Officer | Adicet Bio, Inc. (ACET) | 12-Oct-23 | Payment of Exercise | 7,933 | $1.35 | $10,709.50 | (15%) 54.31K to 46.38K | |
03-Oct-23 4:22 PM View: | Harvey Brian Nicholas Chief Financial Officer | Adicet Bio, Inc. (ACET) | 02-Oct-23 | Payment of Exercise | 7,096 | $1.37 | $9,721.52 | (8%) 84.92K to 77.82K | |
03-Oct-23 4:24 PM View: | Galimi Francesco SVP & Chief Medical Officer | Adicet Bio, Inc. (ACET) | 02-Oct-23 | Payment of Exercise | 8,093 | $1.37 | $11,087.40 | (9%) 88.55K to 80.46K | |
03-Oct-23 4:22 PM View: | Healey Don Chief Technology Officer | Adicet Bio, Inc. (ACET) | 02-Oct-23 | Payment of Exercise | 9,069 | $1.37 | $12,424.50 | (14%) 66.57K to 57.5K | |
02-Oct-23 10:00 PM View: | Schor Chen President & CEO Director | Adicet Bio, Inc. (ACET) | 02-Oct-23 | Payment of Exercise | 23,208 | $1.37 | $31,795.00 | (8%) 273.86K to 250.65K | |
02-Oct-23 10:00 PM View: | Schor Chen President & CEO Director | Adicet Bio, Inc. (ACET) | 02-Oct-23 | Purchase | 5,500 | $1.33 | $7,339.75 | 2% 268.36K to 273.86K | |
02-Oct-23 10:00 PM View: | Schor Chen President & CEO Director | Adicet Bio, Inc. (ACET) | 29-Sep-23 | Sale | 5,500 | $1.36 | $7,480.55 | (2%) 273.86K to 268.36K | |
02-Oct-23 10:00 PM View: | Schor Chen President & CEO Director | Adicet Bio, Inc. (ACET) | 28-Sep-23 | Sale | 5,500 | $1.42 | $7,810.00 | (2%) 279.36K to 273.86K | |
02-Oct-23 10:00 PM View: | Schor Chen President & CEO Director | Adicet Bio, Inc. (ACET) | 28-Sep-23 | Private Purchase | 5,500 | $1.42 | $7,810.00 | 2% 273.86K to 279.36K | |
30-Jun-23 4:08 PM View: | Dubin Steve Director | Adicet Bio, Inc. (ACET) | 30-Jun-23 | Private Purchase | 5,000 | $2.40 | $11,999.50 | 85% 5.9K to 10.9K | |
29-Jun-23 4:51 PM View: | Gordon Carl L Director 10% Owner | Adicet Bio, Inc. (ACET) | 27-Jun-23 | Private Purchase Duplicate | 875,000 | $2.09 | $1,828,750.00 | 12% 7.45M to 8.32M | |
29-Jun-23 4:46 PM View: | Orbimed Advisors LLC Director 10% Owner | Adicet Bio, Inc. (ACET) | 27-Jun-23 | Private Purchase | 875,000 | $2.09 | $1,828,750.00 | 12% 7.45M to 8.32M | |
02-Jun-23 5:48 PM View: | Kauffman Michael Director | Adicet Bio, Inc. (ACET) | 01-Jun-23 | Grant | 5,900 | -- | -- | 100% 0 to 5.9K | |
02-Jun-23 5:47 PM View: | Gordon Carl L Director | Adicet Bio, Inc. (ACET) | 01-Jun-23 | Grant | 5,900 | -- | -- | 100% 0 to 5.9K | |
02-Jun-23 5:48 PM View: | Jakobovits Aya Director | Adicet Bio, Inc. (ACET) | 01-Jun-23 | Grant | 5,900 | -- | -- | < 1% 850.76K to 856.66K | |
02-Jun-23 5:49 PM View: | Sanna Bastiano Director | Adicet Bio, Inc. (ACET) | 01-Jun-23 | Grant | 5,900 | -- | -- | 100% 0 to 5.9K | |
02-Jun-23 5:47 PM View: | Dubin Steve Director | Adicet Bio, Inc. (ACET) | 01-Jun-23 | Grant | 5,900 | -- | -- | 100% 0 to 5.9K | |
02-Jun-23 5:46 PM View: | Sinclair Andrew Director | Adicet Bio, Inc. (ACET) | 01-Jun-23 | Grant | 5,900 | -- | -- | < 1% 2.12M to 2.12M | |
02-Jun-23 5:50 PM View: | Chodakewitz Jeffrey Director | Adicet Bio, Inc. (ACET) | 01-Jun-23 | Grant | 5,900 | -- | -- | 100% 0 to 5.9K | |
17-Feb-23 8:22 PM View: | Healey Don Chief Technology Officer | Adicet Bio, Inc. (ACET) | 15-Feb-23 | Sale (Planned) | 4,533 | $7.57 | $34,326.60 | (6%) 71.1K to 66.57K | |
14-Feb-23 4:50 PM View: | Healey Don Chief Technology Officer | Adicet Bio, Inc. (ACET) | 10-Feb-23 | Sale (Planned) | 10,467 | $7.98 | $83,476.40 | (13%) 81.57K to 71.1K | |
26-Jan-23 4:08 PM View: | Galimi Francesco SVP & Chief Medical Officer | Adicet Bio, Inc. (ACET) | 24-Jan-23 | Grant | 26,100 | -- | -- | 42% 62.45K to 88.55K | |
26-Jan-23 4:06 PM View: | Healey Don Chief Technology Officer | Adicet Bio, Inc. (ACET) | 24-Jan-23 | Grant | 26,100 | -- | -- | 47% 55.47K to 81.57K | |
26-Jan-23 4:05 PM View: | Schor Chen President & CEO Director | Adicet Bio, Inc. (ACET) | 24-Jan-23 | Grant | 85,500 | -- | -- | 59% 144.89K to 230.39K | |
26-Jan-23 4:06 PM View: | Aftab Blake Chief Scientific Officer | Adicet Bio, Inc. (ACET) | 24-Jan-23 | Grant | 26,100 | -- | -- | 93% 28.21K to 54.31K | |
26-Jan-23 4:07 PM View: | Harvey Brian Nicholas Chief Financial Officer | Adicet Bio, Inc. (ACET) | 24-Jan-23 | Grant | 26,100 | -- | -- | 44% 58.82K to 84.92K | |
14-Feb-23 10:00 PM View: | Schor Chen President & CEO Director | Adicet Bio, Inc. (ACET) | 14-Nov-22 | Gift | 9,955 | -- | -- | (6%) 154.85K to 144.89K | |
14-Feb-23 10:00 PM View: | Schor Chen President & CEO Director | Adicet Bio, Inc. (ACET) | 14-Nov-22 | Gift | 9,955 | -- | -- | 7% 144.89K to 154.85K | |
15-Nov-22 4:31 PM View: | Schor Chen President & CEO Director | Adicet Bio, Inc. (ACET) | 10-Nov-22 | Sale (Planned) | 30,000 | $20.06 | $601,920.00 | (17%) 174.89K to 144.89K | |
15-Nov-22 4:32 PM View: | Aftab Blake Chief Scientific Officer | Adicet Bio, Inc. (ACET) | 10-Nov-22 | Private Sale (Planned) | 6,967 | $21.00 | $146,307.00 | (20%) 35.18K to 28.21K |